Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits (PGNMID) is a recently described, uncommon renal disorder which is considered a monoclonal gammopathy of renal significance. Although some patients will have a detectable monoclonal spike, overt hematologic malignancy is foun...

Full description

Bibliographic Details
Main Authors: Jose Torrealba, Jyothsna Gattineni, Allen R. Hendricks
Format: Article
Language:English
Published: Karger Publishers 2018-04-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
Online Access:https://www.karger.com/Article/FullText/488641
id doaj-26e30c13d021425f9421286d518006cf
record_format Article
spelling doaj-26e30c13d021425f9421286d518006cf2020-11-24T23:18:00ZengKarger PublishersCase Reports in Nephrology and Dialysis2296-97052018-04-0181707510.1159/000488641488641Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric CaseJose TorrealbaJyothsna GattineniAllen R. HendricksProliferative glomerulonephritis with monoclonal immunoglobulin G deposits (PGNMID) is a recently described, uncommon renal disorder which is considered a monoclonal gammopathy of renal significance. Although some patients will have a detectable monoclonal spike, overt hematologic malignancy is found in only a minority. Most patients with PGNMID are over the age of 50 years, and to our knowledge no cases have been reported in children or adolescents. Renal biopsy shows variable histologic patterns by light microscopy, with membranoproliferative and membranous patterns being most common. Immunofluorescence microscopy demonstrates restriction to a single immunoglobulin G heavy chain isotype and a single light chain subtype. Electron microscopy reveals granular, unorganized deposits. We report a rare pediatric case which occurred in a 17-year-old female. The rarity of this entity in the adult population has not permitted a standard treatment regimen to be established. Our adolescent patient was treated with multiple treatment regimens including prednisone, mycophenolate mofetil, rituximab, bortezomib, and daratumumab. Our case demonstrates that awareness of this disorder by pediatric nephrologists and pathologists is vital to guide accurate disease classification, prognosis, and treatment.https://www.karger.com/Article/FullText/488641GlomerulonephritisMonoclonal immunoglobulinsImmunoglobulin G
collection DOAJ
language English
format Article
sources DOAJ
author Jose Torrealba
Jyothsna Gattineni
Allen R. Hendricks
spellingShingle Jose Torrealba
Jyothsna Gattineni
Allen R. Hendricks
Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
Case Reports in Nephrology and Dialysis
Glomerulonephritis
Monoclonal immunoglobulins
Immunoglobulin G
author_facet Jose Torrealba
Jyothsna Gattineni
Allen R. Hendricks
author_sort Jose Torrealba
title Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
title_short Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
title_full Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
title_fullStr Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
title_full_unstemmed Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
title_sort proliferative glomerulonephritis with monoclonal immunoglobulin g lambda deposits: report of the first pediatric case
publisher Karger Publishers
series Case Reports in Nephrology and Dialysis
issn 2296-9705
publishDate 2018-04-01
description Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits (PGNMID) is a recently described, uncommon renal disorder which is considered a monoclonal gammopathy of renal significance. Although some patients will have a detectable monoclonal spike, overt hematologic malignancy is found in only a minority. Most patients with PGNMID are over the age of 50 years, and to our knowledge no cases have been reported in children or adolescents. Renal biopsy shows variable histologic patterns by light microscopy, with membranoproliferative and membranous patterns being most common. Immunofluorescence microscopy demonstrates restriction to a single immunoglobulin G heavy chain isotype and a single light chain subtype. Electron microscopy reveals granular, unorganized deposits. We report a rare pediatric case which occurred in a 17-year-old female. The rarity of this entity in the adult population has not permitted a standard treatment regimen to be established. Our adolescent patient was treated with multiple treatment regimens including prednisone, mycophenolate mofetil, rituximab, bortezomib, and daratumumab. Our case demonstrates that awareness of this disorder by pediatric nephrologists and pathologists is vital to guide accurate disease classification, prognosis, and treatment.
topic Glomerulonephritis
Monoclonal immunoglobulins
Immunoglobulin G
url https://www.karger.com/Article/FullText/488641
work_keys_str_mv AT josetorrealba proliferativeglomerulonephritiswithmonoclonalimmunoglobulinglambdadepositsreportofthefirstpediatriccase
AT jyothsnagattineni proliferativeglomerulonephritiswithmonoclonalimmunoglobulinglambdadepositsreportofthefirstpediatriccase
AT allenrhendricks proliferativeglomerulonephritiswithmonoclonalimmunoglobulinglambdadepositsreportofthefirstpediatriccase
_version_ 1725582195603537920